Erlotinib Versus Etoposide/Cisplatin With Radiation Therapy in Unresectable Stage III Epidermal Growth Factor Receptor Mutation-Positive Non-Small Cell Lung Cancer: A Multicenter, Randomized, Open-Label, Phase 2 Trial
- Resource Type
- Article
- Authors
- Xing, Ligang; Wu, Gang; Wang, Luhua; Li, Jiancheng; Wang, Jianhua; Yuan, Zhiyong; Chen, Ming; Xu, Yaping; Fu, Xiaolong ; Zhu, Zhengfei; Lu, You; Han, Chun; Xia, Tingyi; Xie, Conghua; Li, Guang; Ma, Shenglin; Lu, Bing; Lin, Qin; Zhu, Guangying; Qu, Baolin; Zhu, Wanqi; Yu, Jinming
- Source
- In International Journal of Radiation Oncology, Biology, Physics 1 April 2021 109(5):1349-1358
- Subject
- Thoracic Cancer
- Language
- ISSN
- 0360-3016